ArticleBMC cancer2026

Clinical-genomic risk discordance and its impact on treatment selection in premenopausal women with node-positive hormone receptor-positive breast cancer.

Mariko Nishikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.